This website uses cookies to enhance the user experience.
||
G

GRUM INVEST AS991 212 280

Limited company
c/o ECIT Veiby Akonto AS Hvervenmoveien 49 3511 HØNEFOSS, Norge

GRUM INVEST AS

Operating
Eie aksjer og andeler i andre selskaper og sammenslutninger, og aktiviteter i naturlig sammenheng med dette.

Organization

Chairman of the board
Years since formation
19 years
since May 3, 2007
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
1,000
1 share class
Total number of shareholders
1
person

Financials

Annual total result 2025
-2,616,691
NOK
Total equity 2025
24,494,765
NOK
Last update: Jul 23, 2026

Management

Board

NameRoleShares
Chairman
100 %
directly
Alternate Member-

Others

NameRoleShares
C
CROWE PARTNER REVISJON AS
Auditor-
E
ECIT VEIBY AKONTO AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Chairman
100 %
directly
Last update: Nov 28, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
1,000
100 %

Shares owned by the GRUM INVEST AS

NameShare classTotal number of sharesShare
I
INTELLITECH AS
A-shares
121,033
2.14 %
E
EMPLOYEE WELLBEING AS
Ordinary shares
841
2.02 %
G
GROGRO AS
Ordinary shares
1,913
1.82 %
S
SANITY HOLDING AS
Ordinary shares
543,478
0.67 %
N
NORDIC BRAIN TECH AS
Ordinary shares
1,139
0.64 %
P
PICKR AS
Ordinary shares
57,992
0.49 %
S
SNOWCASTLE GAMES AS
Ordinary shares
743
0.47 %
O
OLIO HOLDING AS
Ordinary shares
3,769
0.46 %
H
HUMA AS
A-shares
25,000
0.4 %
D
DILLER HOLDING AS
Ordinary shares
345,775
0.33 %
U
UNLOC AS
Ordinary shares
18,002
0.16 %
K
KRB CAPITAL AS
NO0010842271
62,342
0.13 %
C
CAPSOL TECHNOLOGIES ASA
NO0010923121
45,200
0.07 %
A
AETERNUM CAPITAL AS
G-shares
10,000
0.06 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
100,000
0.03 %
A
AMICOAT AS
NO0010799679
701
< 0.01 %
P
PHARMA HOLDINGS AS
NO0010797350
14
< 0.01 %
P
PHARMASUM THERAPEUTICS AS
Ordinary shares
66
< 0.01 %
J
JOTUN A/S
NO0004543711
7
< 0.01 %
V
VEND MARKETPLACES ASA
NO0003028904
3,000
< 0.01 %
L
LYTIX BIOPHARMA ASA
NO0010405780
1,280
< 0.01 %
E
ERH AS
NO0010350028
188
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
-2,616,691
1,997,141
-1,678,992
6,137,802
-1,014,087
Total assets
26,133,576
27,233,045
25,198,413
26,794,767
21,677,047
Total liabilities
1,638,812
121,590
84,099
1,462
1,021,544
Total equity
24,494,765
27,111,455
25,114,314
26,793,306
20,655,504

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
632,065
568,536
286,671
335,107
135,306
Operating result
-632,065
-568,536
-286,671
-335,107
-135,306
Financial income/costs
-1,916,211
2,575,027
-1,309,929
6,473,688
-875,775
Profit before tax
-2,548,277
2,006,491
-1,596,601
6,138,581
-1,011,081
Total tax & extraordinary income/cost
68,414
9,350
82,391
779
3,006
Annual Total Result
-2,616,691
1,997,141
-1,678,992
6,137,802
-1,014,087

Balance overview

Year20252024202320222021
Total fixed assets
16,539,677
15,256,713
9,722,114
14,895,557
12,776,051
Total current assets
9,593,900
11,976,332
15,476,298
11,899,211
8,900,997
Total assets
26,133,576
27,233,045
25,198,413
26,794,767
21,677,047
Short term debt
1,478,657
29,849
1,708
1,462
1,021,544
Long term debt
160,155
91,741
82,391
0
0
Total liabilities
1,638,812
121,590
84,099
1,462
1,021,544
Contributed capital
30,000
30,000
30,000
30,000
30,000
Retained earnings
24,464,765
27,081,455
25,084,314
26,763,306
20,625,504
Total equity
24,494,765
27,111,455
25,114,314
26,793,306
20,655,504
Total equity and liabilities
26,133,576
27,233,045
25,198,413
26,794,767
21,677,047

Classification

21st company classification
BETA
Small company
Type of organization
Limited company